Back
Akoya Biosciences Vs. Neurogene Industry Stock Comparison
Sell
25
AKYA
Akoya Biosciences
Last Price:
$2.46
Seasonality Move:
-6.47%
Sell
14
NGNE
Neurogene
Last Price:
$24.02
Seasonality Move:
23.27%
Sell
25
Akoya Biosciences (AKYA)
is a Sell
Is Akoya Biosciences a Buy, Sell or Hold?
-
The current Akoya Biosciences [AKYA] share price is $2.41. The Score for AKYA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
AKYA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKYA Stock Price Chart
What is Akoya Biosciences's stock price today?
-
The Akoya Biosciences share price today is $2.41The current trend is relatively stagnant and AKYA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NGNE Stock Price Chart
AKYA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 49.17 | Sell |
Chaikin Money Flow: | 57713 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.13 - 2.43) | Buy |
Bollinger Bands (100): | (2.24 - 2.96) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.24 | Sell |
Relative Strength Index (14 RSI): | 40.31 | Sell |
Chaikin Money Flow: | 33416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.65 - 25.15) | Buy |
Bollinger Bands (100): | (25.64 - 49.84) | Sell |
AKYA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.44 | Sell |
20-day SMA: | 2.32 | Buy |
50-day SMA: | 2.62 | Sell |
200-day SMA: | 2.91 | Sell |
8-day EMA: | 2.42 | Sell |
20-day EMA: | 2.41 | Buy |
50-day EMA: | 2.51 | Sell |
200-day EMA: | 3.1 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23 | Sell |
20-day SMA: | 23.46 | Sell |
50-day SMA: | 36.34 | Sell |
200-day SMA: | 37.73 | Sell |
8-day EMA: | 22.79 | Sell |
20-day EMA: | 24.82 | Sell |
50-day EMA: | 31.38 | Sell |
200-day EMA: | 34.77 | Sell |
Akoya Biosciences Earnings Growth & AKYA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.44 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
Akoya Biosciences Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |